Senti Biosciences Holdings, Inc. (SNTI) total assets
Senti Biosciences Holdings, Inc. (SNTI) had total assets of $51.22M at the end of fiscal 2025 (December 31, 2025). That is 47.6% lower than the $97.84M of fiscal 2024. Figures as of 18 Nov 2026, 13:07 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total assets, fiscal 2025
- $51.22M
- Change on fiscal 2024
- −47.6%
- Highest on record
- $180.79Mfiscal 2022
- Lowest on record
- $51.22Mfiscal 2025
- Fiscal years on record
- 52021–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Senti Biosciences Holdings, Inc. total assets, in more detail
Across the 5 fiscal years on record (2021–2025), the highest was $180.79M in fiscal 2022 and the lowest $51.22M in fiscal 2025.
Total assets by fiscal year
Senti Biosciences Holdings, Inc. total assets, year by year
| Fiscal year | Total assets | Change | Year ended |
|---|---|---|---|
| 2025 | $51.22M | 47.6% down | |
| 2024 | $97.84M | 18.1% down | |
| 2023 | $119.48M | 33.9% down | |
| 2022 | $180.79M | 87.0% up | |
| 2021 | $96.70M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.
How to read it
It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.
Senti Biosciences Holdings, Inc., figure by figure
- Senti Biosciences Holdings, Inc. market cap
- Senti Biosciences Holdings, Inc. revenue
- Senti Biosciences Holdings, Inc. earnings
- Senti Biosciences Holdings, Inc. earnings per share (EPS)
- Senti Biosciences Holdings, Inc. P/E ratio
- Senti Biosciences Holdings, Inc. P/S ratio
- Senti Biosciences Holdings, Inc. P/B ratio
- Senti Biosciences Holdings, Inc. free cash flow
- Senti Biosciences Holdings, Inc. operating margin
- Senti Biosciences Holdings, Inc. dividend
- Senti Biosciences Holdings, Inc. shares outstanding
- Senti Biosciences Holdings, Inc. total debt
- Senti Biosciences Holdings, Inc. cash on hand
- Senti Biosciences Holdings, Inc. return on equity (ROE)
- Senti Biosciences Holdings, Inc. return on invested capital (ROIC)
Senti Biosciences Holdings, Inc. (SNTI) overview: price, valuation and scorecard
Senti Biosciences Holdings, Inc. total assets: questions and answers
How large are Senti Biosciences Holdings, Inc.'s total assets?
Senti Biosciences Holdings, Inc. (SNTI) had total assets of $51.22M at the end of fiscal 2025 (December 31, 2025). That is 47.6% lower than the $97.84M of fiscal 2024.
What are the highest and lowest total assets figures on record for Senti Biosciences Holdings, Inc.?
Across the 5 fiscal years on record (2021–2025), the highest was $180.79M in fiscal 2022 and the lowest $51.22M in fiscal 2025.
How is Senti Biosciences Holdings, Inc.'s total assets calculated?
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Senti Biosciences Holdings, Inc. it is on record here for 5 fiscal years, 2021 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: total assets
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Senti Biosciences Holdings, Inc. (SNTI) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/SNTI/total-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.